Oxford Nanopore Technologies (Oxford Nanopore) has announced the introduction of a new Pharmacogenomics (PGx) Beta Programme to promote personalized medicine. The program combines Twist Bioscience's next generation sequencing (NGS) target...
Biocon Ltd said it has marked a exclusive licensing and supply concurrence with South Korea's Handok for commercialisation of its complex drug product, synthetic Liraglutide, utilized in the therapy of constant weight management. As per the...
Nona Biosciences, a worldwide biotechnology firm that offers a complete solution from “Idea to IND†(I to ITM), going from target approval and neutralizer disclosure through preclinical exploration, reported that it has gone into a license...
SAB Biotherapeutics, a clinical-stage biopharmaceutical firm, stated that the US Food and Drug Administration (FDA) has approved the company's investigational new drug (IND) application to move on with its phase 1 clinical study for type 1...
Emcure Pharmaceuticals Ltd. and its biotech subsidiary, Gennova Biopharmaceuticals Ltd. have amicably resolved all legal disputes with HDT Bio Corp. The litigation between them, including before US courts and the arbitral tribunal in London, has...
Boehringer Ingelheim and OSE Immunotherapeutics SA announced a significant expansion of their partnership. Two new tasks to foster first-in-class treatments will be added to the continuous anti-SIRPa immune oncology programs. The first involves...
Sun Pharmaceutical Industries Ltd revealed a united net profit of Rs 2,654.58 crore in the final quarter ended on March 31, 2024. The organization had posted a merged net benefit of Rs 1,984.47 crore in the final quarter of the past fiscal, Sun...
WHO has accepted the designation of 33 national and regional regulatory agencies as WHO Listed agencies (WLAs), which can be depended on to meet the highest level of regulatory standards and practices for the quality, safety, and efficacy of drugs...
Sanofi, Formation Bio and OpenAI are teaming up to construct AI-powered software to speed up drug advancement and carry new medicines to patients efficiently. The three groups will unite information, programming and tuned models to foster custom...
Dr Reddy's Labs SA has forayed into a license and supply contract with Iceland-based biotech player Alvotech for the commercialisation of AVT03, the latter’s denosumab biosimilar candidate. ATV03 is a biosimilar candidate for Prolia and Xgeva...
.jpg)
